Title : Sacubitril/valsartan effect on left ventricular remodeling: the case of a super-responder.

Pub. Date : 2019 May

PMID : 30894032






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 In consideration of poor response to therapy, we switched angiotensin converting enzyme inhibitor to sacubitril/valsartan to the maximum tolerated dose (49/51 mg bid) with a marked improvement in LV systolic function and reduction in LV volumes at follow-up. Valsartan BH3 interacting domain death agonist Homo sapiens